Science / Ingredient Library
Resveratrol
A plant polyphenol found in the trans form in NMN 9600 PLUS.
Definition and mechanism
Resveratrol occurs in plants and has distinct molecular forms. The product licence identifies trans-resveratrol. Research includes laboratory assays, animal experiments and short human interventions. Differences in assay conditions, study material and endpoints limit how the results can be compared.
Ingredient identity
- Medicinal ingredient
- trans-Resveratrol
- Amount in NMN 9600 PLUS
- 80 mg per capsule
- Source material as listed
- Reynoutria Japonica - root
- Common source name
- Japanese knotweed root
Licensed product information
NMN 9600 PLUS · NPN 80146903
Recommended use or purpose
A factor in normal growth and development.
A factor in the maintenance of good health.
Helps (to) maintain/support the body's ability to metabolize nutrients.
Helps in energy metabolism/(and) tissue formation.
Helps normal growth and development.
NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health.
NMN is a NAD+ precursor which is a factor in normal growth and development.
NMN is a NAD+ precursor which is an important cofactor in energy metabolism.
Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
Supports biological functions which play a key role in the maintenance of good health.
Medicinal ingredients
- NMN · 160 mg per capsule
- Trans-resveratrol · 80 mg per capsule
Recommended dose
Adults 18 years and older: one capsule once daily.
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications or any other health products, as resveratrol may alter their effectiveness.
Selected research
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.
- Study type
- Human randomized crossover trial
- Product relevance
- Ingredient research context; read alongside Poulsen 2013.
- Finding
- The small crossover study reported changes in selected metabolic and mitochondrial measurements.
- Limitations
- Short trial, small selected population and a different dose. Other human trials have not reproduced all metabolic benefits; not a human longevity result.
- Funding and disclosures
- Not fully assessed; independence cannot be assessed from the available disclosure.
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.
- Study type
- Human randomized trial
- Product relevance
- Necessary context for mixed human findings.
- Finding
- Resveratrol did not significantly improve the primary insulin-sensitivity outcome or the measured metabolic and inflammatory outcomes.
- Limitations
- Different dose, design and endpoints from the small positive crossover trial. A high-dose null result does not prove this lower-dose formula ineffective; it does limit blanket metabolic-benefit claims.
- Funding and disclosures
- Investigator-initiated; Danish public and foundation funding listed. Authors reported no other relevant conflicts.
Resveratrol improves health and survival of mice on a high-calorie diet.
- Study type
- Animal study
- Product relevance
- Historical ageing-research context.
- Finding
- Resveratrol improved survival and selected physiological measures compared with the high-calorie-diet control group.
- Limitations
- Specific mouse diet model; not proof of longer life in healthy people. Subsequent standard-diet findings provide additional context.
- Funding and disclosures
- Competing financial interests declared; details require the journal disclosure.
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span.
- Study type
- Animal study
- Product relevance
- Completes the historical story and prevents a selective lifespan claim.
- Finding
- Several age-associated measures improved, but standard-diet mice did not live longer when treatment began in midlife.
- Limitations
- Physiological changes and lifespan are distinct endpoints. Animal results cannot establish human anti-ageing benefits.
- Funding and disclosures
- Not fully assessed; independence cannot be assessed from the available disclosure.
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.
- Study type
- Laboratory and yeast study
- Product relevance
- Explains resveratrol’s early place in ageing research, not evidence for a human longevity regimen.
- Finding
- An early paper reported sirtuin-related activity and longer yeast lifespan under its experimental conditions.
- Limitations
- Historical laboratory finding, not human longevity evidence. Later work questioned assay and substrate dependence; the Kaeberlein study provides additional context.
- Funding and disclosures
- Not fully assessed; independence cannot be assessed from the available disclosure.
Substrate-specific activation of sirtuins by resveratrol.
- Study type
- Laboratory and yeast study
- Product relevance
- Methodological context paired with the 2003 paper.
- Finding
- Activation depended on the assay substrate, and the investigators did not detect the claimed yeast lifespan effect in the tested strains.
- Limitations
- Does not settle every mechanism in later studies. It prevents a simplified claim that resveratrol universally switches on a longevity pathway.
- Funding and disclosures
- Not fully assessed; independence cannot be assessed from the available disclosure.
The cited studies cover ingredient, material or formulation evidence. They do not establish outcomes for a finished DR.MORGAN product.
Related products
Safety and precautions
Read the product warning about medications and other health products. Food exposure and studies of other preparations do not establish suitability for an individual.